Sort
39,280 grants matching “leukemia”
Organizing and Reorganizing Human Testis Development In Vitro
$523,911Kyle E Orwig · Magee-Women'S Res Inst And Foundation · R01 · FY2024 · HD
PolQ as a novel therapeutic target in AML
$523,880Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2023 · CA
Ethnic Differences in Survival after Childhood ALL
$523,875City Of Hope/Beckman Research Institute · R01 · FY2005 · CA
Transcriptional response to signaling during hematopoiesis
$523,832Leonard I Zon · Boston Children'S Hospital · R01 · FY2022 · HL
Role of Runx1 in Pathologic Ocular Angiogenesis
$523,600Leo A Kim · Schepens Eye Research Institute · R01 · FY2019 · EY
Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy
$523,587Weiqiang Chen · New York University · R01 · FY2021 · CA
RNA Polymerase II as a Therapeutic Target in Acute Myeloid Leukemia (AML) with RAS Signaling Activation
$523,510Catherine Choy Smith · University Of California, San Francisco · R01 · FY2024 · CA
Novel combination therapy for AML expressing mutant RUNX1
$523,503Courtney Dinardo · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Novel combination therapy for AML expressing mutant RUNX1
$523,503Courtney Dinardo · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Wnt signaling in hematopoietic development
$523,447David Traver · University Of California, San Diego · R01 · FY2018 · HL
Wnt signaling in hematopoietic development
$523,447David Traver · University Of California, San Diego · R01 · FY2019 · HL
Wnt signaling in hematopoietic development
$523,447David Traver · University Of California, San Diego · R01 · FY2017 · HL
Wnt signaling in hematopoietic development
$523,447David Traver · University Of California, San Diego · R01 · FY2020 · HL
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia
$523,359Nicholas Chiorazzi · Feinstein Institute For Medical Research · R01 · FY2020 · CA
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia
$523,308Nicholas Chiorazzi · Feinstein Institute For Medical Research · R01 · FY2024 · CA
The Brooklyn Minority-Based Community Clinical Oncology Program
$523,248William Barney Solomon · Suny Downstate Medical Center · U10 · FY2009 · CA
Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies
$523,187John C Byrd · Ohio State University · R01 · FY2017 · CA
Dopaminergic Neuromodulation of Decision Making in Young and Middle-Aged Adults
$523,154David H Zald · Vanderbilt University · R01 · FY2017 · AG
Studies of Occupational Cancer
$523,142Qing Lan · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
AML mutation-guided drugging of DNA repair
$523,054Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2024 · CA
Assessing the Interplay Between Inflammatory Signaling and Epigenetic Dysregulation in Age-associated Clonal Hematopoiesis and Leukemia Initiation
$523,054Jennifer Jean Trowbridge · Jackson Laboratory · U01 · FY2024 · AG
In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy
$522,993Craig Lewis Duvall · Vanderbilt University · R01 · FY2024 · CA
Cytokine control of hematopoiesis and leukemias
$522,984Lothar Hennighausen · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK
Inflammation as determinant of clonal selection in MPN progression
$522,957Nadia Carlesso · Beckman Research Institute/City Of Hope · R01 · FY2021 · HL
BCR-ABL Kinase Assays for STI571 Sensitivity of Response
$522,923University Of Chicago · R33 · FY2005 · CA